These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 16505008)

  • 1. Proteomic analysis of uveal melanoma reveals novel potential markers involved in tumor progression.
    Zuidervaart W; Hensbergen PJ; Wong MC; Deelder AM; Tensen CP; Jager MJ; Gruis NA
    Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):786-93. PubMed ID: 16505008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MMP-2 expression in uveal melanoma: differential activation status dictated by the cellular environment.
    Bérubé M; Deschambeault A; Boucher M; Germain L; Petitclerc E; Guérin SL
    Mol Vis; 2005 Dec; 11():1101-11. PubMed ID: 16379022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteome analysis of a human uveal melanoma primary cell culture by 2-DE and MS.
    Pardo M; García A; Thomas B; Piñeiro A; Akoulitchev A; Dwek RA; Zitzmann N
    Proteomics; 2005 Dec; 5(18):4980-93. PubMed ID: 16267820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of fourteen proteins between uveal melanoma from patients who subsequently developed distant metastases versus those who did Not.
    Linge A; Kennedy S; O'Flynn D; Beatty S; Moriarty P; Henry M; Clynes M; Larkin A; Meleady P
    Invest Ophthalmol Vis Sci; 2012 Jul; 53(8):4634-43. PubMed ID: 22570344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic analysis of membrane rafts of melanoma cells identifies protein patterns characteristic of the tumor progression stage.
    Baruthio F; Quadroni M; Rüegg C; Mariotti A
    Proteomics; 2008 Nov; 8(22):4733-47. PubMed ID: 18942674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cripto-1 expression in uveal melanoma: an immunohistochemical study.
    Mallikarjuna K; Vaijayanthi P; Krishnakumar S
    Exp Eye Res; 2007 Jun; 84(6):1060-6. PubMed ID: 17412323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomics of uveal melanomas suggests HSP-27 as a possible surrogate marker of chromosome 3 loss.
    Coupland SE; Vorum H; Mandal N; Kalirai H; Honoré B; Urbak SF; Lake SL; Dopierala J; Damato B
    Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):12-20. PubMed ID: 19643972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apoptosis inhibitor, survivin, in posterior uveal melanoma: comparison among primary tumors, tumors resistant to brachytherapy, tumors with liver metastases, and liver metastases.
    Ben Simon GJ; Abulafia A; Pe'er J
    Curr Eye Res; 2006 Mar; 31(3):251-7. PubMed ID: 16531282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using the direct-injection model of early uveal melanoma hepatic metastasis to identify TPS as a potentially useful serum biomarker.
    Barak V; Frenkel S; Valyi-Nagy K; Leach L; Apushkin MA; Lin AY; Kalickman I; Baumann NA; Pe'er J; Maniotis AJ; Folberg R
    Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4399-402. PubMed ID: 17898257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic analysis of differentially expressed proteins involving in liver metastasis of human colorectal carcinoma.
    Li SY; An P; Cai HY; Bai X; Zhang YN; Yu B; Zuo FY; Chen G
    Hepatobiliary Pancreat Dis Int; 2010 Apr; 9(2):149-53. PubMed ID: 20382585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of chemokine receptors on uveal melanoma cells and their metastases.
    Li H; Alizadeh H; Niederkorn JY
    Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):636-43. PubMed ID: 18235009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteopontin and 'melanoma inhibitory activity': comparison of two serological tumor markers in metastatic uveal melanoma patients.
    Haritoglou I; Wolf A; Maier T; Haritoglou C; Hein R; Schaller UC
    Ophthalmologica; 2009; 223(4):239-43. PubMed ID: 19270465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for natural killer cell-mediated protection from metastasis formation in uveal melanoma patients.
    Maat W; van der Slik AR; Verhoeven DH; Alizadeh BZ; Ly LV; Verduijn W; Luyten GP; Mulder A; van Hall T; Koning F; Jager MJ; van Bergen J
    Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2888-95. PubMed ID: 19234348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient isolation and quantitative proteomic analysis of cancer cell plasma membrane proteins for identification of metastasis-associated cell surface markers.
    Lund R; Leth-Larsen R; Jensen ON; Ditzel HJ
    J Proteome Res; 2009 Jun; 8(6):3078-90. PubMed ID: 19341246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Entering a new era of rational biomarker discovery for early detection of melanoma metastases: secretome analysis of associated stroma cells.
    Paulitschke V; Kunstfeld R; Mohr T; Slany A; Micksche M; Drach J; Zielinski C; Pehamberger H; Gerner C
    J Proteome Res; 2009 May; 8(5):2501-10. PubMed ID: 19222175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characteristics of liver metastases from uveal melanoma.
    Meir T; Dror R; Yu X; Qian J; Simon I; Pe'er J; Chowers I
    Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):4890-6. PubMed ID: 17962435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biologic determinants of uveal melanoma metastatic phenotype: role of intermediate filaments as predictive markers.
    Hendrix MJ; Seftor EA; Seftor RE; Gardner LM; Boldt HC; Meyer M; Pe'er J; Folberg R
    Lab Invest; 1998 Feb; 78(2):153-63. PubMed ID: 9484713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative proteomic analysis of matched primary and metastatic melanoma cell lines.
    Al-Ghoul M; Brück TB; Lauer-Fields JL; Asirvatham VS; Zapata C; Kerr RG; Fields GB
    J Proteome Res; 2008 Sep; 7(9):4107-18. PubMed ID: 18698805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profiling of nuclear extract proteins from human neuroblastoma cell lines: the search for fingerprints.
    Escobar MA; Hoelz DJ; Sandoval JA; Hickey RJ; Grosfeld JL; Malkas LH
    J Pediatr Surg; 2005 Feb; 40(2):349-58. PubMed ID: 15750928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular pathways mediating liver metastasis in patients with uveal melanoma.
    Bakalian S; Marshall JC; Logan P; Faingold D; Maloney S; Di Cesare S; Martins C; Fernandes BF; Burnier MN
    Clin Cancer Res; 2008 Feb; 14(4):951-6. PubMed ID: 18281525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.